Abstract: Aim: was to evaluate the effectiveness of endovascular interventions in patients with critical limb ischemia (CLI) with multilevel extended lesions of lower limb arteries of types C and D according to TASC II. Materials and methods: a retrospective analysis of results of surgical treatment of patients with critical limb ischemia, who underwent 127 endovascular interventions on arteries of the femoral- popliteal-tibial segment for the period from 2007 to 2020, was carried out. 15 patients had ischemic limb pain at rest (11,8%) and 112 patients had trophic lesions (88,2%). Our study included patients with arterial lesions of type C (18 patients, 14,2%) and type D (109 patients, 85,8%) according to TASC II. Results: technical success of performed endovascular interventions was 95,3%. Within a 30-day period, 2 patients (1,6%) had myocardial infarction, 3 patients (2,4%) underwent early «high» amputation. Perioperative mortality was 0,8% (1 patient). Primary patency of endovascular interventions was 87%, 58% and 36% after 1, 3 and 5 years, respectively, while secondary patency was 91%, 81% and 58% after 1, 3 and 5 years, respectively. Limb salvage rate was 93%, 89% and 79% after 1, 3 and 5 years, respectively. Patient survival rate was 95%, 84% and 78% after 1, 3 and 5 years, respectively. Conclusions: endovascular interventions on femoral-popliteal-tibial arterial lesions of types C and D according to TASC II in patients with critical limb ischemia are effective, and modern method of treatment with good immediate and long-term results. References 1. Conte MC, Bradbury AW, Kolh Ph, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Journal of Vascular Surgery. 2019; 69(6): 123-125. https://doi.org/10.1016/j.jvs.2019.02.016 2. Pokrovskij AV, Ivandeev AS. Sostojanie sosudistoj hirurgii v Rossii v 2016 godu. M.: Obshhestvo angiologov i sosudistyh hirurgov. Moskva. 2017; 76 [In Russ]. 3. Barriocanal АM, L?pez A, Monreal M, Montan? E. Quality assessment of peripheral artery disease clinical guidelines. J Vascular Surgery. 2016; 63(4): 1091-1097. https://doi.org/10.1016/j.jvs.2015.12.040 4. Farber A, Eberhardt RT. The Current State of Critical Limb Ischemia. A Systematic Review. JAMA Surg. 2016; 151(11): 1070-1077. https://doi.org/10.1001/jamasurg.2016.2018 5. Agarwal S, Sud K, Shishehbor MH. Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: from 2003-2011. J Am Coll Cardiol. 2016; 67(16): 1901-1913. https://doi.org/10.1016/j.jacc.2016.02.040 6. Duff S, Mafilio MS, Bhounsul P, Hasegawa JT. The burden of critical limb ischemia: a review of recent literature. Vascular Health and Risk Management. 2019; 15: 187-208. https://doi.org/10.2147/VHRM.S209241 7. Darling JD, McCallum JC, Soden PA, et al. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia. J Vasc Surg. 2017; 66(2): 466-475. https://doi.org/10.1016/j.jvs.2017.01.024 8. Antoniou GA, Georgiadis GS, Antoniou SA, et al. Bypass surgery for chronic lower limb ischemia (Review). Cochrane Database of Systematic Reviews. 2017; 3(4): CD002000. https://doi.org/10.1002/14651858.CD002000.pub3 9. Uccioli L, Meloni M, Izzo V, et al. Critical limb ischemia: current challenges and future prospects. Vascular Health and Risk Management. 2018; 14: 63-74. https://doi.org/10.2147/VHRM.S125065 10. Norgren L, Patel MR, Hiatt WR, et al. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial. Eur J Vasc Endovasc Surg. 2018; 55: 109-117. https://doi.org/10.1016/j.ejvs.2017.11.006 11. Spillerov? К, et al. Angiosome Targeted PTA is More Important in Endovascular Revascularisation than in Surgical Revascularisation: Analysis of 545 Patients with Ischaemic Tissue Lesions. Eur J Vasc Endovasc Surg. 2017; 3: 1-9. https://doi.org/10.1016/j.ejvs.2017.01.008 12. Pokrovskij AV, Kazakov YuI, Lukin IB. Kriticheskaja ishemija nizhnih konechnostej. Ifraingvinal'noe porazhenie. M.: Tver': Tver. Gos. Un-e. 2018; 225 [In Russ]. 13. Aboyans V, Ricco JB, Bartelink ME, et al. Editor’s choiced 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018; 55: 305-368. https://doi.org/10.1093/eurheartj/ehx095 14. Brouillet J, Deloose K, Goueffic Y, et al. Primary stenting for TASC C and D femoropopliteal lesions: one-year results from a multicentric trial on 203 patients. The Journal of Cardiovascular Surgery. 2018; 59(3): 392-404. https://doi.org/10.23736/S0021-9509.16.09282-X 15. Schreuder SM, Hendrix Y, Reekers JA, Bipat S. Predictive Parameters for Clinical Outcome in Patients with Critical Limb Ischemia Who Underwent Percutaneous Transluminal Angioplasty (PTA): A Systematic Review. Cardiovasc Intervent Radiol. 2018; 41(1): 1-20. https://doi.org/10.1007/s00270-017-1796-9 16. Norgren L, Patel MR, Hiatt WR, et al. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial. Eur J Vasc Endovasc Surg. 2018; 55: 109-117. https://doi.org/10.1016/j.ejvs.2017.11.006 17. Papojan SA, Shhegolev AA, Radchenko AN, et al. Otdalennye rezul'taty jendovaskuljarnogo lechenija porazhenij poverhnostnoj bedrennoj arterii tipov S i D po klassifikacii TASC II. Angiologija i sosudistaja hirurgija. 2018; 24(1): 73-78 [In Russ]. 18. Biagioni RB, Biagioni LC, Nasser F, et al. Infrapopliteal Angioplasty of One or More than One Artery for Critical Limb Ischaemia: A Randomised Clinical Trial. Eur J Vasc Endovasc Surg. 2018; 55: 518-527. https://doi.org/10.1016/j.ejvs.2017.12.022 19. Schneider PA, Laird JR, Tepe G, et al. Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial. Circ Cardiovasc Interv. 2018; 11 (1): 885-891. https://doi.org/10.1161/CIRCINTERVENTIONS.117.005891 20. Reijnen MJ. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study. J Endovasc Ther. 2019; 26: 305-315.
Abstract: Infra-popliteal lesions rarely were the zone of interest in first years of endovascular era. Nowadays, broad worldwide experience of transluminal interventions and appearance of low-profile instruments allowed broadening of the indications for transluminal repair of the below-the-knee arteries. The method is proved to be safe and effective. Results of 121 angioplasties in 70 patients with chronic ischemia of the legs (12 years work of a city hospital) are analyzed in the article. The main indication was stenotic and occlusive infrapopliteal lesions excluding the possibilities of bypass surgery. It was shown that the endovascular approach is extremely effective, and in cases of diabetic angiopathy and critical lower extremities ischemia, an endovascular intervention can be not only the way to save a leg, but the only way to save the patient's life. Reference 1. Sprayregen S., Sniderman K.W., Sos Т.А. et al. Popliteal artery branches: percutaneous transluminal angioplasty. Am. I. Roentgenol. 1980; 135: 945-950. 2. Sivananthan U.M., Browne T.F., Thorley P.J., Rees M.R. Percutaneous transluminal angioplasty of the tibial arteries. Br. J. Surg. 1994; 81 (9): 1282-1285. 3. Baum S., Pentecost M.J. Infrapopliteal revascularization. Abrams angiography interventional radiology second edition. 2006;348-261. 4. Dorros G., Jaff M.R., Kelly K.J. et al. The acuteoutcome of tibioperoneal vessel angioplasty in417 cases with claudication and critical limbischemia. Cathet. Cardiovasc. Diagn. 1998; 45: 251-256.. 5. Alfkel H. Long-term results after infrapopliteal/CIRSE. Италия. 2006.Покровский А.В. Состояние сосудистой хирургии в России в 2006 году. М. 2007; 9-13. 6. Rizzati R., Tartari S.. Infra-popliteal revascu larization in critical limb ischemia: three year experience in endovascular and surgical treatment/CIRSE. Италия. 2006; 191. 7. Tsetis D., Belli A.M. The role of infrapopliteal angioplasty. Br. J. Radiol. 2004; 77 (924): 1007-1015. 8. Затевахин И.И., Шиповский В.Н., Золкин В.Н. Баллонная ангиопластика при ишемии нижних конечностей. М.: Медицина. 2004; 231-249. 9. Siablis D., Karпabatidis D., Katsanos К. Infrapopliteal paclitaxel-eluting stents for critical limb ischemia: six-month clinical and angiographic results/CIRSE. Италия. 2006; 196. 10. Зеленов М.А., Ерошкин И.А., Коков Л.С. Особенности ангиографической картины у больных с сахарным диабетом с окклюзионно-стенотическим поражением артерий нижних конечностей. Диагностическая и интервенционная радиология: 2007; 1 (2): 22-30.
Abstract: The aim of the study was to define the factors, having influence to results of repeated percutaneous coronary interventions (PCI) such as isolated balloon angioplasty (BA) and BA in combination with rotational atherectomy (RA), used for treatment of stenosis inside stented segments of coronary arteries. 133 patients, submitted to repeated PCI due to development of stenosis in the stented coronary segments, were included in the study. Clinical and angiographic data were registered three times: at time of initial stenting, during repeated PCI and after 18 monthes of follow-up. Repeated PCI were done together with intracoronary ultrasonography. Decrease of neointimal volume and degree of balloon hyperinflation had not any influence on clinical end-points. Cross-luminal area of the vessel was the only significant prognostic facor for success of repeated PCI. Borderline value of the area was 4,7 sq.mm. Combined technique of PCI (BA + RA) had advantages over isolated BA only in those cases, when large cross-sectional lumen area must be achieved. Good clinical results of patients with cross-sectional lumen area >4,7 sq.mm, obtained after repeated PCI, give possoibility not to use additional interventions. If sufficient increase of the vessel lumen area can not be achieved, an active approach to therapy of such patients should be used after PCI. The only significant beneficial prognostic factor for success of repeated PCA of the stenosed stented coronary segments was area of the vessels's lumen. It did not depend on technique of revascularisation. Such factors, as decrease of neointimal volume and degree of balloon hyperinflation, had not influence on frequency of restenosis and clinical end-points. References 1. Bauters С, Banos J.L., Van BelleE., McFadden E., Lablanche J.M., Bertrand M. Six months outcome after successful repeat percutaneous intervention for in stent restenosis. Circulation.1998; 97: 318-321. 2. Elchaninof H., Koning R., Tron C, Gupta V, Cribier A. Balloon angioplasty for the treatment of coronary in stent restenosis: immediate results and 6-month angiographic recurrent restenosis rate. J. Am. Coll. Cardiology .1998; 32:980-984. 3. Reimers В., Moussa I., Akiyama T. et al. long term clinical follow-up after successful repeat percutaneous intervention for stent restenosis. J. Am. Coll. Cardiology.1997; 30: 186-192. 4. Sharma S., Kini A., Garapati A. et al. Randomized trial of rotational atherectomy vs balloon angioplasty for in stent restenosis (Abstr.). Circulation.1998; 98 (1): 511. 5. Yokoi H., Kimura Т., Nakagawa Y, Nosaka H., Nouyoshi M. Long term clinical and quantitative angiographic follow-up after the Palmaz-Schatz stent restenosis. / Am. Coll. Cardiology.1993; 76: 618-622. 6. Mehran R., Dangas G., Mintz G. et al. In stent restenosis: «the great equalizer». Disappointing clinical outcomes with all interventional strategies (Abstr.). J. Am. Coll. Cardiology. 1999; 33: 1129-1191. 7. Mehran R., Mintz G.S., Popma JJ. et al. Mechanisms and results of balloon angioplasty for the treatment of in stent restenosis. Am. J. Cardiology. 1996; 78; 618-622. 8. Schiele E, Vuillemenot A., Meneveau N., Pales-Espinosa D., Gupta S., Bassand J.P. Effects of increasing balloon pressure on mechanism and results of balloon an gioplasty for treatment of restenosis after Palmaz-Schatz stent implantation. An angiographic and intra vascular ultrasound study. Cathet. Cardiovasc. Diagn. 1999; 46 (4): 3321. 9. Goldberg S.L., Berger P.B., Cohen DJ. et al. balloon angioplasty versus rotational atherectomy for in stent restenosis (abstr.). Circulation. 1998; 98 (1): 363. 10. Mehran R., Mintz G., Satler L. et al. Treatment of in stent restenosis with eximer laser coronary angioplasty. Mechanism and results compared to PTCA alone. Cir culation. 1997; 96: 2183-2189. 11. Dauerman H., Bairn D., Cutlip E. et al Mechanical debulking versus balloon angioplasty for the treatment of diffuse in stent restenosis. Am.]. Cardiol. 1998; 82: 277-284. 12. Lee S., Whan C, Cheong S. et al. Immediate and long term outcomes of rotational atherectomy versus balloon angioplasty alone for treatment of diffuse in stent restenosis. Am. J. Cardiology.1998; 82: 140-143. 13. Mahdi N.A., Pathan A.Z., Harrel L. et al. Directional atherectomy for the treatment of Palmaz-Schatz in stent restenosis. Am.]. Cardiology. 1998; 82: 1345-1351. 14. Kini A., Sharma S.K., Dangas G., Vidhun R., Duvvuri S. Marmur J. Predictors of restenosis after rotational at herectomy for in-stent restenosis (abstr.). Circulation.1998; 98 {!): 111. 15. Vom Dahl J., Radke P., Haage P. et al. Clinical and an giographic predictors of recurrent restenosis after percutaneous transluminal rotational atherectomy for treatment of diffuse in stent restenosis. Am. J. Cardiology.1999; 833: 862-867. 16. Schiele E, Meneveau N., Vuillemenot A. et al. Impact of intravascular ultrasound guidance in stent deployment on 6 month restenosis rate. J. Am. Coll. Cardiology. 1998; 32: 320-328.
|
authors:
|
Abstract: The article gives account of coronary stenting impact on the dynamics of left ventricle index. The study covered 94 postinfarction patients, including 80 men and 14 women. Among them 52 patients with Q-forming myocardium infarction and 42 with non-Q myocardium infarction were observed. 1 3 patients that suffered Q-forming myocardium infarction didn't show any segment contractility disorders (group 1), while 39 showed contractility disorders (group 2). The analysis revealed that index improvement of the left ventricle is observed in the 1st group in 77% cases after stenting, while the 2nd group shows no improvements. Among the 2nd group of patients the full recovery is observed in 21% cases, the partial recovery - in 46% and 1 3% didn't overcome any dynamics. The EchoCG study performed on 42 patients revealed that 31 men have no segmental activity disorders (group 3) and 1 1 suffered segmental activity disorder (group 4). Stenting procedure improved the myocardium function in the 3rd group in 65% cases. In the long prospect 1 0 patients of the 4th group fully recovered their myocardium function and only 1 man showed no dynamics in contractility improvement. Taking into consideration what has been said one can be sure that EchoCG proves to be an effective method of valuing the left ventricle function improvement before and after coronary stenting. References 1. Бокерия А.А. Современное общество и сердечно-сосудистая хирургия. Тезисы докладов V Всероссийского съезда сердечно-сосудистых хирургов. М., 1999; 3-6. 2. Чазов Е.И. Проблемы борьбы с сердечно-сосудистыми заболеваниями. Кардиология. 1973; 2: 5-10. 3. Белов Ю.В., Вараксин В.А. Современное представление о постинфарктном ремоделировании левого желудочка. Русский медицинский журнал. 2002; 10: 469-471. 4. Самко А.Н. Применение интракоронарных стентов ДЛЯ лечения больных ишемической болезнью сердца. Русский медицинский журнал. 1998; 6(14): 923-927. 5. Мазур Н.А. Эффективные и безопасные методы лечения больных хронической ишемической болезнью сердца. Русский медицинский журнал. 1998; 6(14): 908-913. 6. Петросян Ю.С., Зингерман Л.С. Классификация атеросклеротических изменений коронарных артерпи. Тезисы докл. 1 и 2 Всесоюзных симпозиумов по современным методам селективной ангиографии и их применение в клинике. М., 1973; 16. 7. Петросян Ю.С., Иоселиани Д.Г. О суммарной оценке состояния коронарного русла у больных ишемической болезнью сердца. Кардиология. 1976; 12(16): 41-46. 8. Петросян Ю.С., Шахов Б.Е. Коронарное русло у больных с постинфарктной аневризмой левого желудочка сердца. Горький. 1983; 17-20. 9. Bourdillon P.D.V, Broderick T.M., Sawada S.G, Armstrong WE, Ryan., Dillon J.C., Fineberg N.S., and Feigenbaum H.: Regional wall motion index for infarct and noninfarct regions after reperfusion in acute myocardial infarction: Comparison with globalwall motion index./. Am. Soc. Echocardiogr. 1989; 2: 398. 10. Фейгенбаум Харви «Эхокардиография». М.: Видар. 1999; 115-119. 11. Otto СМ., Pearlmann A.S. Textbook of clinical echocardiograph.
Abstract: A multicentered study based on retrospective data covered 2012 patients and aimed at ascertaining the eficiency of various methods of treating patients with coronary restenosis after stenting. The average percent of complications after restenosis was about 20% during the period of study (1 1+4 months). The metaregression data analysis showed the positive correlation between the stage of residual stenosis of the stentet segment and the probability of complications. As the residual stenosis decreased at 1%, the frequency of complications diminished at 0,9%. Another factors under analysis did not show any evident influence, although we have registered a tendency towards better outcomes of the recurring operations as the diameter of the vessel increased. The recurring balloon angioplasty in cases of short restenosis and intracoronar radiation in cases of diffused restenotic lesions have proved to be the most effective operations. The indications for implanting the additional stents must be given very carefully, especially in cases of diabetes. References 1. Fischman D.L., Leon M.D., Baim D.S., et al. A randomized comparison of coronary stent placement and balloon angioplasty in treatment of coronary artery disease. N. Engl. J. Med. 1994; 331: 496 - 501. 2. Serruys P.W, de Jaeger P., Kimeneij E, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary heart disease. N. Engl]. Med. 1994; 331: 489 - 495. 3. Di Mario C, Marsico E, Adamian M. et al. New recipes for in-stent restenosis: cut, grate, roast, or sandwich the neointima? Heart. 2000; 84: 471 - 475. 4. Hoffmann R., Mintz G. S. Coronary in-stent restenosis-predictors, treatment and prevention. Eur. Heart J. 2000; 21: 1739- 1749. 5. Leon M.B., Tierstein P.S., Moses J.W et al. Localized intracoronary gamma-radiation therapy to inhibit the occurrence of restenosis after stenting. N. Egl. J. Med. 2001; 344: 250-256. 6. Waksman R., White R.L., Chan R.C., et al. Intracoronary gamma-radiation therapy after angioplasty inhibits reccurence in patients with in-stent restenosis. Circulation. 2000; 101: 2165 - 2171. 7. Sousa J. E., Costa M.A., Abizaid A., et al. Lack of neoitimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2001; 10: 192 - 195. 8. Kuntz R.E., Gibson СМ., Nobuyoshi M., et al. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J. Am. Coll. Cardiology. 1993; 21: 15 - 25.
Abstract: Purpose: on the basis of long-term results of renal angioplasty and stenting, the authors define the indications for endovascular interventions in patients with renovascular hypertension (RVH). Materials and methods: since 1992-2008 in Tashkent Medical Academy Vascular Surgery Center were performed 131 endovascular interventions in 119 patients for renal arteries (RA) stenoses of various origins. 97 patients underwent balloon angioplasty (BA) of renal arteries (105 interventions), and stenting was performed in 22 cases (26 stenting procedures). Systolic blood pressure varied from 170 to 300 mm Hg (219,4±23,1 mmHg), with diastolic blood pressure from 170 to 300 mm Hg (118,1±8,9 mm Hg). Average arterial hypertension history was 5,2±3,7 years (6 months - 16 years). Results: technical success rate was 85,6% for balloon angioplasty, and 100 % for stenting procedures. Immediate hypotensive effect was good to satisfactory. Complication rate was 2,5% (3 patients). Long-term results were assessed in 76 cases of balloon angioplasty (78,4%), and in all patients with renal arteries stenting. The average follow-up was 72±32,5 months (6-144 months) for balloon angioplasty, and 6-24 months for stenting group. In the angioplasty group long-term hypotensive effect lasted in 54(71,1%) of patients, and the restenosis rate was as high as 28,9% (22 cases). In the stenting group, the long-term hypotensive effect was preserved in all the patients, and there were no cases of restenosis. Conclusions: high rates of technical and clinical success, as well as low rates of restenosis, allow the renal artery stenting procedure to be seen as the method of choice for renovascular hypertension. References 1. Клиническая ангиология в 2 томах. Под редакцией А.В. Покровского. М.: Медицина. 2004; 2: 94-114. 2. Алекян Б.Г., Бузиашвили Ю.И., Голухова Е.З. и др. Ближайшие и отдаленные результаты стентирования почечных артерий у больных с вазоренальной гипертензией. Ангиология и сосудистая хирургия. 2006;1: 55-62. 3. Carmo M., Bower T.C. Surgical мanagement of renal fibromuscular dysplasia. Challenges 11.in the endovascular era. Ann. Vasc. Surgery. 2005; 19: 208-217. 4. Baert A.L., Wilms G., Amery A., Vermylen J.,Suy R. Percutaneous transluminal renal angioplasty: initial results and long-term follow-up in 202 patients. Cardiovasc. Intervent. Radiol. 1990; 13: 22-28. 5. WongJ.M., Hansen K.J., Oskin T.C. et al. Surgery after failed percutaneous renal artery angioplasty.J. Vasc. Surg. 1999; 30: 468-483. 6. Yutan E., Glickerman D.J., Caps M.T. et al.Percutaneous transluminal revascularizationfor renal artery stenosis. Veterans affairs puget sound health care system experience. J. Vasc. Surg. 2001; 34: 685-693. 7. Петровский Б.В., Гавриленко А.В. 40-летний опыт реконструктивных операций при вазоренальной гипертензии. Ангиология и сосудистая хирургия. 2003; 2: 8-12. 8. Троицкий А.В., Елагин О.С., Хабазов Р.И. и др. Одномоментная реконструкция висцеральных ветвей аорты и почечных артерий. Ангиология и сосудистая хирургия. 2006; 2: 132-136. 9. Крылов В.П., Реут Л.И., Дергачева И.М. и соавт. Отдаленные результаты хирургического лечения вазоренальной гипертензии. Клиническая кардиология. 2004; 2: 34-39. 10. Bonelli F.S., McKusick M.A., Textor S.C. et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo. Clinic. Proc. 1995; 70: 1041-1052. 11. Surowiec S.M., Sivamurthy N., Rhodes J.M. et al. Percutaneous therapy for renal artery fibromuscular dysplasia. Ann. Vasc. Surg. 2003; 17: 650-655. 12. Galaria I.I., Surowiec S.M., Jeffrey M. Percutaneous and оpen renal revascularizations have equivalent long-term functional outcomes. Ann. Vasc. Surg. 2005; 25: 218-224.
Abstract: Article describes results of single-balloon angioplasty and stenting in patients with occlusive-stenotic lesions of femoral-popliteal segment for the period of 30 months. It was performed 209 endovascular interventions, single-balloon angioplasty in 95 patients; stenting - 114 patients. Long-term results of primary patency: 43,1% in group of single-balloon angioplasty 57,1% - in group with stenting. References 1. Рекомендуемые стандарты для оценки результатов лечения пациентов с хронической ишемией нижних конечностей. Российский консенсус. Казань 2001. Rekomenduemye standarty dlja ocenki rezul'tatov lechenija pacientov s hronicheskoj ishemiej nizhnih konechnostej. Rossijskij consensus [Recommended standarts for estimation of treatment results in patients with chronic ischemia of lower limbs. Russian Consensus]. Kazan' 2001 [ In Russ]. 2. Klinicheskaja angiologija [Clinical angiology]. Pod red. akad. Pokrovskogo A.V. M., 2004; 1: 69 [In Russ]. 3. Nacional'nye rekomendacii po vedeniju bol'nyh s zabolevanijami arterij nizhnih konechnostej [National recommendation for treatment of patients with diseases of lower limbs’ arteries.]. M., 2013[In Russ]. 4. Hunink M.M., Donaldson M.C., Meyerovitz M.F., et al. Risks and benefits of femoropopliteal percutaneous balloon angioplasty. J. Vasc. Surg. 1993; 17: 183-194. 5. Becquemin J-P, Cavillon A., Haiduc F. Surgical transluminal femoropopliteal angioplasty: multivariate analysis outcome. J. Vasc .Surg .1994; 19: 495-502. 6. Murray R.R., Hewes R.C., White R.I., et al. Long-segment femoropopliteal stenoses: is angioplasty a boom or a bust? Radiology .1987; 162: 473-476. 7. Johnston K.W. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992; 183:767-71. 8. Krankenberg H., Schluter M., Steinkamp H.J., et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST). Circulation. 2007; 116:285-92. 9. Dake M., Ansel G., Jaff M., et al. Zilver PTX: a prospective, randomized trial of the polymer-free paclitax-eleluting stent compared to balloon angioplasty with provisional bare metal stenting in patients with superficial femoral artery disease (abstr). Paper presented at: Twenty-Second Annual Transcatheter Cardiovascular Therapeutics Symposium;September 21-25; Washington, DC. J. Am. Coll. Cardiol. 2010;56:xiii. 10. Bergeron P., Pinot J.J., Poyen V., et al. Long-term results with the Palmaz stent in the superficial femoral artery. J. Endovasc. Surg. 1995; 2: 161-167. 11. Henry M., Amor M., Henry I., et al. Placement of Palmaz stent in femoropopliteal arteries: a six year experience. Factors influencing restenosis and longterm results. In: Abstract Book 6° International course on peripheral vascular intervention. Oct 1995, Nancy, France. 12. Dake M., Ansel G., Jaff M., et al. Zilver PTX: a prospective, randomized trial of the polymer-free paclitax-eleluting stent compared to balloon angioplasty with provisional bare metal stenting in patients with superficial femoral artery disease (abstr). Paper presented at: Twenty-Second Annual Transcatheter Cardiovascular Therapeutics Symposium;September 21-25; Washington, DC. J. Am. Coll. Cardiol. 2010;56.
